Dr. Dasari is a medical oncologist in the Dept of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center .
As a member of Southwest Oncology Group (SWOG) and NRG Oncology, he serves on their GI, Colorectal Cancers and Neuroendocrine Committees.
He serves as the SWOG subcommittee co-Chair for NET and on the NET Task Force
His primary research focus is in phase I-III clinical trial development using novel therapeutics inclusive of blood and tissue correlatives for biomarker discovery and enhanced drug utilization in the treatment of gastrointestinal malignancies with a focus on colorectal and neuroendocrine cancers.
He currently leads several ongoing trials in neuroendocrine tumors and colorectal cancers